Chemomab Therapeutics
(NASDAQ:CMMB)
$2.36
-0.09[-3.67%]
Last update: 11:12AM
Day Range2.35 - 2.4552 Wk Range2.25 - 7.54Open / Close2.45 / -Float / Outstanding8.1M / 11.4M
Vol / Avg.12.5K / 36.6KMkt Cap27MP/E-50d Avg. Price3.17
Div / Yield-Payout Ratio-Total Float8.1MEPS-0.54

Chemomab Therapeutics Stock (NASDAQ:CMMB), Quotes and News Summary

Chemomab Therapeutics Stock (NASDAQ: CMMB)

Day Range2.35 - 2.4552 Wk Range2.25 - 7.54Open / Close2.45 / -Float / Outstanding8.1M / 11.4M
Vol / Avg.12.5K / 36.6KMkt Cap27MP/E-50d Avg. Price3.17
Div / Yield-Payout Ratio-Total Float8.1MEPS-0.54
Sector: Health Care.Industry: Biotechnology
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need. The company's lead candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-11
REV
Q2 2022Est.ActualSurprise
EPS-0.250-0.540 -0.2900
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Chemomab Therapeutics Questions & Answers

Q
How do I buy Chemomab Therapeutics (CMMB) stock?
A

You can purchase shares of Chemomab Therapeutics (NASDAQ: CMMB) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Chemomab Therapeutics's (CMMB) competitors?
Q
What is the target price for Chemomab Therapeutics (CMMB) stock?
A

The latest price target for Chemomab Therapeutics (NASDAQ: CMMB) was reported by Oppenheimer on Thursday, March 10, 2022. The analyst firm set a price target for 20.00 expecting CMMB to rise to within 12 months (a possible 747.46% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Chemomab Therapeutics (CMMB)?
A

The stock price for Chemomab Therapeutics (NASDAQ: CMMB) is $2.36 last updated Today at October 5, 2022, 3:12 PM UTC.

Q
Does Chemomab Therapeutics (CMMB) pay a dividend?
A

There are no upcoming dividends for Chemomab Therapeutics.

Q
When is Chemomab Therapeutics (NASDAQ:CMMB) reporting earnings?
A

Chemomab Therapeutics’s Q3 earnings are confirmed for Friday, November 11, 2022.

Q
Is Chemomab Therapeutics (CMMB) going to split?
A

There is no upcoming split for Chemomab Therapeutics.

Q
What sector and industry does Chemomab Therapeutics (CMMB) operate in?
A

Chemomab Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.